作者: Atheer Awad , Sarah J. Trenfield , Simon Gaisford , Abdul W. Basit
DOI: 10.1016/J.IJPHARM.2018.07.024
关键词:
摘要: Abstract Three-dimensional printing (3DP) is a highly disruptive technology with the potential to change the way pharmaceuticals are designed, prescribed and produced. Owing to its low cost, diversity, portability and simplicity, fused deposition modeling (FDM) is well suited to a multitude of pharmaceutical applications in digital health. Favourably, through the combination of digital and genomic technologies, FDM enables the remote fabrication of drug delivery systems from 3D models having unique shapes, sizes and …